Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for BioRestorative Therapies (BRTX) over the last 14 years, with Q3 2025 value amounting to $612064.0.

  • BioRestorative Therapies' Other Non Operating Income fell 4094.69% to $612064.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 525300.65%. This contributed to the annual value of $150850.0 for FY2024, which is 9622.67% down from last year.
  • As of Q3 2025, BioRestorative Therapies' Other Non Operating Income stood at $612064.0, which was down 4094.69% from $574591.0 recorded in Q2 2025.
  • BioRestorative Therapies' Other Non Operating Income's 5-year high stood at $7.7 million during Q3 2023, with a 5-year trough of -$2.7 million in Q2 2023.
  • Moreover, its 4-year median value for Other Non Operating Income was $521224.0 (2023), whereas its average is $789229.2.
  • As far as peak fluctuations go, BioRestorative Therapies' Other Non Operating Income skyrocketed by 4461372.95% in 2023, and later plummeted by 52552.32% in 2025.
  • BioRestorative Therapies' Other Non Operating Income (Quarter) stood at $5.3 million in 2022, then tumbled by 90.15% to $521224.0 in 2023, then skyrocketed by 89.61% to $988316.0 in 2024, then crashed by 38.07% to $612064.0 in 2025.
  • Its Other Non Operating Income was $612064.0 in Q3 2025, compared to $574591.0 in Q2 2025 and -$634119.0 in Q1 2025.